The mRNA and protein levels of PHF5A were significantly upregulated in both TCGA mRNA–seq data set and our own NSCLC patient tumor samples, and the expression level of PHF5A was significantly negatively correlated with patient outcomes in LUAD but not in LUSC. Here, PHF5A is linked to non-small cell lung carcinoma.